194 related articles for article (PubMed ID: 19733948)
1. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.
Raj DS; Carrero JJ; Shah VO; Qureshi AR; Bárány P; Heimbürger O; Lindholm B; Ferguson J; Moseley PL; Stenvinkel P
Am J Kidney Dis; 2009 Dec; 54(6):1072-80. PubMed ID: 19733948
[TBL] [Abstract][Full Text] [Related]
2. Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis.
Raj DS; Shah VO; Rambod M; Kovesdy CP; Kalantar-Zadeh K
Am J Kidney Dis; 2009 Dec; 54(6):1062-71. PubMed ID: 19699018
[TBL] [Abstract][Full Text] [Related]
3. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
Navarro-González JF; Mora-Fernández C; Muros de Fuentes M; Donate-Correa J; Cazaña-Pérez V; García-Pérez J
Clin J Am Soc Nephrol; 2011 Sep; 6(9):2272-9. PubMed ID: 21784820
[TBL] [Abstract][Full Text] [Related]
4. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
[TBL] [Abstract][Full Text] [Related]
5. Serum Lipopolysaccharide-Binding Protein is Associated with Chronic Inflammation and Metabolic Syndrome in Hemodialysis Patients.
Lim PS; Chang YK; Wu TK
Blood Purif; 2019; 47(1-3):28-36. PubMed ID: 30219816
[TBL] [Abstract][Full Text] [Related]
6. Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.
Feroze U; Kalantar-Zadeh K; Sterling KA; Molnar MZ; Noori N; Benner D; Shah V; Dwivedi R; Becker K; Kovesdy CP; Raj DS
J Ren Nutr; 2012 May; 22(3):317-26. PubMed ID: 21880509
[TBL] [Abstract][Full Text] [Related]
7. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
[TBL] [Abstract][Full Text] [Related]
8. Relation between Soluble CD14 Levels, Inflammation, Subclinical Atherosclerosis and Mortality in Hemodialysis Patients.
Abdallah AM; Elhakeem H; Yahia MB; Youssef EMI; El-Khouly N; Elmohaseb GF; Awad EA; Hassan MM; Ghamry EM; Abdelhamed MR; Kotb E; Mahmoud TM
Endocr Metab Immune Disord Drug Targets; 2023; 23(6):843-849. PubMed ID: 36221874
[TBL] [Abstract][Full Text] [Related]
9. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
Taylor BS; So-Armah K; Tate JP; Marconi VC; Koethe JR; Bedimo RJ; Butt AA; Gibert CL; Goetz MB; Rodriguez-Barradas MC; Womack JA; Gerschenson M; Lo Re V; Rimland D; Yin MT; Leaf D; Tracy RP; Justice AC; Freiberg MS
J Acquir Immune Defic Syndr; 2017 Aug; 75(5):500-508. PubMed ID: 28696344
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD14 and
Shitole SG; Biggs ML; Reiner AP; Mukamal KJ; Djoussé L; Ix JH; Barzilay JI; Tracy RP; Siscovick D; Kizer JR
Diabetes Care; 2019 Nov; 42(11):2075-2082. PubMed ID: 31471378
[TBL] [Abstract][Full Text] [Related]
12. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimbürger O; Bárány P; Stenvinkel P
Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD14 and endotoxin levels in hemodialysis patients: a tale of 2 molecules.
Seabra VF; Thomas G; Jaber BL
Am J Kidney Dis; 2009 Dec; 54(6):990-2. PubMed ID: 19932875
[No Abstract] [Full Text] [Related]
14. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients.
Kwan BC; Chow KM; Ma TK; Cheng PM; Leung CB; Li PK; Szeto CC
Nephron Clin Pract; 2013; 123(3-4):246-53. PubMed ID: 24008429
[TBL] [Abstract][Full Text] [Related]
15. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.
Rambod M; Bross R; Zitterkoph J; Benner D; Pithia J; Colman S; Kovesdy CP; Kopple JD; Kalantar-Zadeh K
Am J Kidney Dis; 2009 Feb; 53(2):298-309. PubMed ID: 19070949
[TBL] [Abstract][Full Text] [Related]
16. CD14 is an acute-phase protein.
Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
[TBL] [Abstract][Full Text] [Related]
17. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients.
Lee CT; Lee CH; Su Y; Chuang YC; Tsai TL; Cheni JB
Int J Artif Organs; 2004 Oct; 27(10):835-41. PubMed ID: 15560677
[TBL] [Abstract][Full Text] [Related]
18. Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
So-Armah KA; Tate JP; Chang CH; Butt AA; Gerschenson M; Gibert CL; Leaf D; Rimland D; Rodriguez-Barradas MC; Budoff MJ; Samet JH; Kuller LH; Deeks SG; Crothers K; Tracy RP; Crane HM; Sajadi MM; Tindle HA; Justice AC; Freiberg MS;
J Acquir Immune Defic Syndr; 2016 Jun; 72(2):206-213. PubMed ID: 27824677
[TBL] [Abstract][Full Text] [Related]
19. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.
Lakatos PL; Kiss LS; Palatka K; Altorjay I; Antal-Szalmas P; Palyu E; Udvardy M; Molnar T; Farkas K; Veres G; Harsfalvi J; Papp J; Papp M
Inflamm Bowel Dis; 2011 Mar; 17(3):767-77. PubMed ID: 20865702
[TBL] [Abstract][Full Text] [Related]
20. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease.
Pastor Rojo O; López San Román A; Albéniz Arbizu E; de la Hera Martínez A; Ripoll Sevillano E; Albillos Martínez A
Inflamm Bowel Dis; 2007 Mar; 13(3):269-77. PubMed ID: 17206721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
